IDL Biotech is a diagnostic company that develops, produces, and markets In Vitro Diagnostic (IVD) tests worldwide for the health care sector. We are active in the fields of oncology and bacteriology through manufacturing of various tumor markers and a rapid Salmonella typhoid test. IDL Biotech AB (publ) is a public company listed on the Swedish equities market place, Aktietorget.
IDL's products enable disease diagnosis and prognosis, control of treatment efficiency, and prolong the interval between more invasive patient examinations.
We are located just outside Stockholm, Sweden, where all company functions, including management, sales & marketing, orders & shipping, R&D, production, and quality assurance can be found.
IDL's products are distributed primarily in Europe and Asia through a network of international business partners.
In 1988, IDL was founded under the name IDL Immuno Develop Lab. 10 years later the company name was changed to IDL Biotech AB (publ). IDL Biotech AB (publ) has been listed on the Swedish equities market place, Aktietorget, since 1999.